Merck Global Health Innovation Fund (MGHIF) is a growth investor in digital health and data science companies, aiming to enhance biopharmaceutical operations and patient care. Founded in 2010, the fund manages over $600M and has made 60+ investments, focusing on early to growth-stage technologies in drug discovery, clinical development, manufacturing, supply chain, IT, and patient support.
Recent Transactions involving Merck Global Health Innovation Fund
Deal | Target | Platform | Buyer | Industry |
---|---|---|---|---|
New Investment in Infectious Disease Connect Fuels World-Class ID Telemedicine Services and Analytics |
Infectious Disease Connect |
UPMC EnterprisesFirst TrustMerck Global Health Innovation Fund |
Hospitals and Health Care | |
|
|
|
||
|
|
|
||
|
|
|
The Lower and Middle Market M&A Platform
See how PrivSource can help you close more deals.
Learn more →